Use of mitoxantrone in neuromyelitis optica.

Use of mitoxantrone in neuromyelitis optica.

Dettagli Bibliografici
Autori principali:	Kitley, J, Leite, M, Matthews, L, Palace, J
Natura:	Journal article
Lingua:	English
Pubblicazione:	2011

Documenti analoghi

Pain in neuromyelitis optica spectrum disease: a cross-sectional study in an English cohort
di: Leonard, H, et al.
Pubblicazione: (2012)

The borderland of neuromyelitis optica.
di: Matthews, L, et al.
Pubblicazione: (2009)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
di: Kitley, J, et al.
Pubblicazione: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
di: Kitley, J, et al.
Pubblicazione: (2014)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
di: Kitley, J, et al.
Pubblicazione: (2012)

NEUROMYELITIS OPTICA SPECTRUM DISORDER AND CMV RETINITIS: A CASE REPORT
di: George, J, et al.
Pubblicazione: (2012)

Seasonal pattern of variation in neuromyelitis optica relapses
di: Elsone, L, et al.
Pubblicazione: (2012)

LONGITUDINALLY EXTENSIVE TRANSVERSE MYELITIS: A VARIETY OF CAUSES SEEN WITHIN THE NATIONAL NEUROMYELITIS OPTICA SERVICE
di: Kitley, J, et al.
Pubblicazione: (2012)

NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND
di: Luppe, S, et al.
Pubblicazione: (2012)

A clinical/immunological neuromyelitis optica association study
di: Kitley, J, et al.
Pubblicazione: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
di: Matthews, L, et al.
Pubblicazione: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
di: Matthews, L, et al.
Pubblicazione: (2013)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
di: Kitley, J, et al.
Pubblicazione: (2012)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
di: Collongues, N, et al.
Pubblicazione: (2013)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
di: Kitley, J, et al.
Pubblicazione: (2013)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
di: Elsone, L, et al.
Pubblicazione: (2012)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
di: Waters, P, et al.
Pubblicazione: (2015)

A practical guide to the treatment of neuromyelitis optica.
di: Palace, J, et al.
Pubblicazione: (2012)

Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
di: Jacob, A, et al.
Pubblicazione: (2012)

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
di: Kitley, J, et al.
Pubblicazione: (2014)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
di: Kitley, J, et al.
Pubblicazione: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
di: Kitley, J, et al.
Pubblicazione: (2013)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
di: Kim, W, et al.
Pubblicazione: (2012)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
di: Kitley, J, et al.
Pubblicazione: (2013)

CAN MRI BE USED AS A DIAGNOSTIC TOOL IN NEUROMYELITIS OPTICA SPECTRUM DISORDER?
di: Matthews, L, et al.
Pubblicazione: (2012)

Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica
di: Kitley, J, et al.
Pubblicazione: (2011)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
di: Nour, M, et al.
Pubblicazione: (2014)

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
di: Absoud, M, et al.
Pubblicazione: (2014)

Magnetic resonance imaging in neuromyelitis optica.
di: Tackley, G, et al.
Pubblicazione: (2014)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
di: Kitley, J, et al.
Pubblicazione: (2014)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
di: Kitley, J, et al.
Pubblicazione: (2014)

MYELIN-OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY AS A CAUSE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS WITH A NEUROMYELITIS OPTICA-LIKE PHENOTYPE IN ADULTS
di: Kitley, J, et al.
Pubblicazione: (2012)

The evolving clinical spectrum of neuromyelitis optica
di: Viegas, S, et al.
Pubblicazione: (2008)

Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.
di: Fujihara, K, et al.
Pubblicazione: (2014)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
di: Downer, J, et al.
Pubblicazione: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
di: Downer, J, et al.
Pubblicazione: (2012)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
di: Viegas, S, et al.
Pubblicazione: (2009)

Treatment of Neuromyelitis Optica: Review and Recommendations.
di: Kimbrough, D, et al.
Pubblicazione: (2012)

Is azathioprine effective in highly-active neuromyelitis optica? A multicentre study from the United Kingdom
di: Elsone, L, et al.
Pubblicazione: (2013)

A mathematical model of cellular swelling in Neuromyelitis optica
di: Laranjeira, S, et al.
Pubblicazione: (2017)